scholarly journals Effect of Below-Knee Compression Garments on Delayed-Onset Muscle Soreness (DOMS): A Randomized Controlled Laboratory Study With Multi-Parametric Analysis

2020 ◽  
Author(s):  
Thilo Hotfiel ◽  
Svenja Höger ◽  
Armin M. Nagel ◽  
Michael Uder ◽  
Wolfgang Kemmler ◽  
...  
Keyword(s):  
Laboratory Study ◽  
Muscle Soreness ◽  
Delayed Onset Muscle Soreness ◽  
Functional Evaluation ◽  
Jump Height ◽  
Calf Circumference ◽  
Compression Garments ◽  
Post Exercise ◽  
Delayed Onset ◽  
Plyometric Exercise

Abstract Background: The impact of compression on overexertion-related muscle injuries such as delayed-onset muscle soreness (DOMS) is a subject of controversy. Identifying the mechanisms, optimal conditions, and application settings under which compression therapy may alter muscle metabolism and improve recovery is crucial. The purpose of this study was to investigate the effects of wearing below-knee compression garments during exercise and a post-exercise period of 6 hours on clinical, functional, and morphological outcomes in DOMS in the lower limb.Methods: Eighteen healthy volunteers (age: 24.1 ±3.6 years, BMI 22.7 ± 2.7 kg/m2) were enrolled in this controlled laboratory study. Repeated measures were aquired at baseline (T0), 6 h (T1), and 48 h (T2) after a standardized eccentric and plyometric exercise protocol, with the participants wearing a compression garment (21-22 mmHg) on a randomly selected calf during and for the first 6 h after exercise. Magnet resonance imaging (MRI) was performed using a 3T scanner for quantification of intramuscular edema (T2 signal intensity (SI), T2 time, and manual volume segmentation); jump height, calf circumference, ankle dorsiflexion (DF), creatine kinase (CK) levels, and muscle soreness were assessed for clinical and functional evaluation. Results: DOMS was confirmed in all participants after 48 h, with a significant increase in muscle soreness (p < 0.001) and CK levels (p = 0.001), decrease in jump height (p < 0.01), and the presence of intramuscular edema (p < 0.01) in both the compressed and non-compressed limbs. No differences between the compressed and non-compressed limbs were observed for muscle soreness and jump height at any point in time. Similarly, MRI T2 SI, T2 time, soreness, and manual segmentation revealed no significant effect of the compression treatment. The assessment of calf circumference and DF showed no statistically significant changes at any point of time in either the compression or non-compression limb (p = 1.0). Conclusions: The continuous application of below-knee compression garments during combined eccentric and plyometric exercise and until 6 h post-exercise has no significant effect on clinical signs of DOMS, jump performance, or the development of intramuscular edema observed in MRI.

scholarly journals Multi-Parametric Analysis of Below-Knee Compression Garments on Delayed-Onset Muscle Soreness

2021 ◽  
Vol 18 (7) ◽  
pp. 3798
Author(s):  
Thilo Hotfiel ◽  
Svenja Höger ◽  
Armin M. Nagel ◽  
Michael Uder ◽  
Wolfgang Kemmler ◽  
...  
Keyword(s):  
Muscle Soreness ◽  
Clinical Signs ◽  
Delayed Onset Muscle Soreness ◽  
Jump Height ◽  
Calf Circumference ◽  
Jump Performance ◽  
Compression Garments ◽  
Post Exercise ◽  
Delayed Onset ◽  
Plyometric Exercise

To investigate below-knee compression garments during exercise and a post-exercise period of 6 h on clinical, functional, and morphological outcomes in delayed-onset muscle soreness (DOMS). Eighteen volunteers (age: 24.1 ± 3.6, BMI 22.7 ± 2.7 kg/m2) were enrolled. Measures were acquired at baseline, 6 h, and 48 h after eccentric and plyometric exercise, with wearing a compression garment (21–22 mmHg) on a calf during and for the first 6 h after exercise. 3T MRI was performed for quantification of intramuscular edema (T2 signal intensity (SI), T2 time, and manual volume segmentation); jump height, calf circumference, ankle dorsiflexion (DF), creatine kinase (CK), and muscle soreness were assessed. DOMS was confirmed in all participants after 48 h, with an increase in soreness (p < 0.001) and CK (p = 0.001), decrease in jump height (p < 0.01), and the presence of intramuscular edema (p < 0.01) in both the compressed and non-compressed limbs. No differences between the compressed and non-compressed limbs were observed for muscle soreness and jump height. MRI T2 SI, T2 time, soreness, and manual segmentation revealed no effect of the compression treatment. The assessment of calf circumference and DF showed no changes in either the compression or non-compression limb (p = 1.0). Wearing compression garments during combined eccentric and plyometric exercise and for 6 h post-exercise has no effect on clinical signs of DOMS, jump performance, or the development of intramuscular edema.

scholarly journals Post exercise protein ingestion does not attenuate delayed onset muscle soreness

2006 ◽  
Vol 20 (5) ◽  
Author(s):  
Andrew Philp ◽  
Timothy Etheridge ◽  
Peter W Watt
Keyword(s):  
Muscle Soreness ◽  
Delayed Onset Muscle Soreness ◽  
Post Exercise ◽  
Delayed Onset ◽  
Protein Ingestion

scholarly journals Compression garments to prevent delayed onset muscle soreness in soccer players

2019 ◽  
Vol 03 (04) ◽  
pp. 295 ◽  
Author(s):  
X. Valle ◽  
L. Til ◽  
F. Drobnic ◽  
A. Turmo ◽  
J.B. Montoro ◽  
...  
Keyword(s):  
Muscle Soreness ◽  
Delayed Onset Muscle Soreness ◽  
Soccer Players ◽  
Compression Garments ◽  
Delayed Onset

scholarly journals Post-exercise effects of graduated compression garment use on skeletal muscle recovery and delayed onset muscle soreness: a systematic review

Motricidade ◽  
2018 ◽  
Vol 14 (2-3) ◽  
pp. 129-137 ◽  
Author(s):  
Aline Machado Araujo ◽  
Rodrigo Kohn Cardoso ◽  
Airton José Rombaldi
Keyword(s):  
Methodological Quality ◽  
Muscle Soreness ◽  
Delayed Onset Muscle Soreness ◽  
Compression Stockings ◽  
Muscle Recovery ◽  
Post Exercise ◽  
Positive Effects ◽  
Delayed Onset ◽  
Delayed Muscle Soreness

The study aimed to review the literature on the effects related to post-exercise of graduated compression garments (GCGs) use on muscle recovery and delayed onset muscle soreness. The search was performed in Pubmed/Medline, Bireme, Scielo, and Lilacs electronic databases using the following descriptors in English: "compression clothing", "physical exercise", "recovery", "physical activity", "compression stockings" and "delayed onset muscle soreness". The search resulted in 102 articles and after removing duplicates, applying exclusion criteria and checking the reference lists, nine studies fulfilled the criteria and were included in the review. Seven studies associated the use of GCGs with reduction of delayed muscle soreness and improvement in performance after the use of compression clothes. However, the methodological quality of the studies, using PEDro scale, presented an average of 5.1±0.9 points (out of a total of 11 points), classified as intermediate. In conclusion, although the positive effects of using CGCs on improving recovery and reduction of delayed muscle soreness after physical exercises are almost consensual, the insufficient methodological quality of the included studies requires careful consideration of the results.

scholarly journals Effect of curcumin supplement or placebo in delayed onset muscle soreness: a systematic review and meta-analysis

2021 ◽  
Vol 45 (1) ◽  
Author(s):  
Natthanichar Rattanaseth ◽  
Patteera Panyarapeepat ◽  
Janisa Andrea Muljadi ◽  
Kornkit Chaijenkij ◽  
Jatupon Kongtharvonskul
Keyword(s):  
Muscle Soreness ◽  
Meta Analysis ◽  
Delayed Onset Muscle Soreness ◽  
Main Body ◽  
Level Of Evidence ◽  
Post Exercise ◽  
Multiple Strategies ◽  
Delayed Onset ◽  
Tnf Α ◽  
Exercise Induced

Abstract Background There are multiple strategies that have been suggested to attenuate delayed onset muscle soreness (DOMS). Curcumin has been shown to reduce exercise-induced oxidative stress (OS) and inflammation. However, currently, there is still controversy. Main body of the abstract We conduct this meta-analysis according to the PRISMA guidelines. Relevant studies were included from Medline and Scopus from the date of inception to May 04th, 2021 that reported VAS score, blood markers (creatinine kinese (CK), tumor necrotic factor (TNF)-α and interleukin (IL)-6) and range of motion of either group. There were total of 13 studies including 202 and 176 persons in curcumin and placebo group. The unstandardized mean difference (UMD) of VAS muscle soreness in post-exercise, 1, 2, 3 and 4 days was − 0.12 (95% CI − 0.46, 0.22), − 0.38 (− 0.83, 0.08), − 0.67 (− 1.19, − 0.16), − 0.86 (− 1.38, − 0.34), − 0.81 (− 1.27, − 036) and − 1.24 (− 1.50, − 0.99) scores lower in curcumin when compared to placebo. The UMD of CK was − 11.07 (95% CI − 24, 1.86), − 37.51 (− 68.04, − 6.97), − 45.40 (− 95.67, 4.86), − 53.33 (− 128.11, 21.45), − 90.98 (− 173.45, − 8.51) and 117.84 (− 338.69, 574.37) lower in curcumin when compared to placebo. No statistically significantly differences were noted for IL-6, TNF-α and ROM between two groups. Short conclusion This meta-analysis suggested that curcumin supplement reduced delayed onset muscle soreness and CK after exercise in 1, 2, 3, and 4 days when compared to placebo. However, TNF and IL were not affected by curcumin ingestion. Level of evidence I.

scholarly journals Effect of caffeine on delayed-onset muscle soreness: a meta-analysis of RCT

2021 ◽  
Vol 45 (1) ◽  
Author(s):  
Janisa Andrea Maljadi ◽  
Patsorn Kaewphongsri ◽  
Kornkit Chaijenkij ◽  
Jatupon Kongtharvonskul
Keyword(s):  
Placebo Group ◽  
Muscle Soreness ◽  
Meta Analysis ◽  
Delayed Onset Muscle Soreness ◽  
Main Body ◽  
Level Of Evidence ◽  
Post Exercise ◽  
Multiple Strategies ◽  
Delayed Onset ◽  
Group A

Abstract Background There are multiple strategies that have been suggested to attenuate delayed-onset muscle soreness (DOMS). Caffeine has been shown to assist with blocking pain associated with DOMS. However, currently there is still controversy over the effects of caffeine use. Main body We conducted a meta-analysis to compare pain associated with muscle soreness by both the VAS and indirect markers by CK of caffeine and placebo after exercise. The meta-analysis was carried out in accordance with the PRISMA guidelines. Relevant studies from Medline and Scopus published up to May 20, 2021, were included, which resulted in a total of 477 and 132 studies being retrieved from Scopus and Medline, respectively. Seven studies met the inclusion criteria, and in these, there were 68 persons in the caffeine group and 74 persons in the placebo group. A visual analog score of muscle soreness was recorded pre-exercise, immediately post-exercise, and at one to four days post-exercise; the scores at these time points in the caffeine group as compared to those in the placebo group progressed from 0.00 (95% CI − 0.51, 0.50) to − 0.20 (− 1.09, 0.69), − 0.92 (− 2.20, 0.36), − 1.02 (− 1.86, − 0.19), 0.00 (− 0.36, 0.36), and 0.18 (− 0.56, 0.92), respectively. No statistically significant differences were noted for CK between the two groups at 24 h post-exercise. Short conclusion Our meta-analysis results indicate that caffeine supplements reduce delayed-onset muscle soreness when compared to a placebo 48 h after exercise. However, at 24 h post-exercise, caffeine can reduce DOMS only in people who worked on resistant exercise. The CK used in this meta-analysis did not show any differences. Trial registration: PROSPERO CRD42021260248. Level of evidence I.

Sign in / Sign up

Export Citation Format

Share Document